A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation

Annals of Emergency Medicine

Volumn 36, Issue 1, 2000, Pages 1-9

  Joseph, Anthony P ^a,b   Ward, Michael R ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; SOTALOL;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; STROKE; TACHYCARDIA;

EID: 0033886309     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2000.107655     Document Type: Article

References (30)

1. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation
2. Epidemiologic features of chronic atrial fibrillation: The Framingham study
3. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology. American Heart Association
4. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
5. Left ventricular function in patients with atrial fibrillation before and after cardioversion
6. Left atrial appendage contractile function in atrial fibrillation. Influence of heart rate and cardioversion to sinus rhythm
7. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
8. Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombofic therapy
9. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
10. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I
11. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
12. Electrical remodeling in atrial fibrillation. Time course and mechanisms
13. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm
14. Avoiding drug problems. The safety of drugs for supraventricular tachycardia
15. Proarrhythmia with class III antiarrhythmic drugs: Types, risks, and management
16. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators
17. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomised double-blinded trial
18. Cellular electropharmacology of amiodarone
19. Evidence-based analysis of amiodarone efficacy and safety
20. Efficacy of amiodarone for the termination of persistent atrial fibrillation
21. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study
22. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation
23. Conversion of recent-onset atrial fibrillation to sinus rhythm: Effects of different drug protocols
24. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study
25. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: A placebo-controlled study
26. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine
27. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial)
28. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation
29. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study
30. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo